Fluvoxamine Maleate
Overview
Fluvoxamine Maleate is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat obsessive-compulsive disorder (OCD). It is also prescribed for managing major depressive disorders and anxiety disorders.
API suppliers (7)
Suppliers of Fluvoxamine Maleate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 7 suppliers.
2 of 7 hold a GMP certificate on record in the EU or UK registers
- TAPI NL BVNetherlands1 active DMF
- MEDICHEM SASpain1 active DMF GMP on record
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
- Jewim Pharmaceutical (shandong) Co., Ltd.China1 active DMF
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD1 active DMF
- VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPA
- DIOSYNTH BV
Therapeutic areas
Do you supply Fluvoxamine Maleate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.